Fig. 1 · Structure

Documents & Downloads

Muscimol hydrobromide

Cat. No. A13459 CAS 18174-72-6

GABA(A) receptor agonist

Muscimol hydrobromide is a potent but toxic structural analog of g-aminobutyric acid (GABA), with a zwitterionic structure.

In Stock

Publications for Muscimol hydrobromide

1 publication citing this product

  1. Shi, Mengting, .et al. , Acupuncture and Herbal Medicine, 2025, 5(2):p 217-228

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Muscimol hydrobromide was used as a GABAA receptor agonist in developing mouse thalamic slices. At 20 μM, the calcium-responsive neuronal fraction decreased between P14 and P15. This model-dependent response cautions against assuming uniform neuronal silencing; calcium imaging alone does not establish inhibitory polarity. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

In Vitro Studies

Developmental variation in muscimol-evoked calcium responses

Cell-based study · Acute VPm thalamic slices from C57BL/6J mice, P11, P14, P15 and P17 [1]

Cal-520-positive, SR101-negative neurons showed a smaller calcium-responsive fraction at P15 than P14. P11 versus P14 and P15 versus P17 comparisons were nonsignificant. Figure 5 reports 162, 83, 102 and 42 cells, respectively; these are cell counts, not animal counts.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Fraction of neurons with increased calcium fluorescence after muscimol, compared across agesBetween-age comparison P14 vs P15: p < 0.001; P11 vs P14 and P15 vs P17: n.s.[1]

Literature-Reported Treatment Conditions

Treatment concentration
20 μM
Method
Bath application after a stable fluorescence baseline; images acquired every 3 s.
Vehicle
ACSF was the imaging medium; stock solvent was not specified in the imaging methods.
Reported limits
Exposure duration, stock solvent and animal-level replication for the imaging comparison are not specified in the relevant methods/caption. No antagonist control is reported for Figure 5 calcium imaging.
Methods and source locations

Compound reported in the paper: Muscimol hydrobromide; Compound label in the paper: Sigma M1523

Evidence concerns the named salt from Sigma. It does not establish Adooq lot performance or a receptor potency value.

Figure 5A–D and caption; Results paragraph immediately preceding Figure 5; Materials and Methods: Brain Slice Ca2+ Imaging; Discussion, final paragraph

Fraction of neurons with increased calcium fluorescence after muscimol, compared across ages: Confocal calcium imaging; Figure 5C significance brackets; caption specifies Student’s t-test and SEM. — Figure 5B–D image and caption; Brain Slice Ca2+ Imaging

Specifications

Manufacturer Adooq Bioscience
Actions Agonist
CAS Number 18174-72-6
Applications GABA(A) receptor agonist
Formula C4H6N2O2.BrH
Molecular Weight 195.01
SMILES
C1=C(ONC1=O)CN.Br

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Research References

  1. [1] Libiao Pan, Junhua Yang, Qian Yang, et al. A Critical Period for the Rapid Modification of Synaptic Properties at the VPm Relay Synapse Frontiers in Molecular Neuroscience (2017). PMID: 28790892 DOI: 10.3389/fnmol.2017.00238 Source material

Publications

1 publication citing this product

  1. Shi, Mengting, .et al. , Acupuncture and Herbal Medicine, 2025, 5(2):p 217-228

Added to your cart

View Cart Checkout
Loading...